Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid

Free Radical Research

Volumn 25, Issue 4, 1996, Pages 337-346

  Ou, Piemian ^a   Nourooz Zadeh, Jaffar ^a   Tritschler, Hans J ^b   Wolff, Simon ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ASTA MEDICA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ASCORBIC ACID; CATALASE; COPPER; COPPER COMPLEX; HYDROGEN PEROXIDE; IMIRESTAT; LIPID HYDROPEROXIDE; METAL ION; SORBINIL; SORBITOL; THIOCTIC ACID; UNCLASSIFIED DRUG; ZEOPOLASTAT;

ANIMAL TISSUE; ARTICLE; CHELATION; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVATION; ERYTHROCYTE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IRON CHELATION; LENS; LIPID PEROXIDATION; LIPOPHILICITY; NONHUMAN; NORMAL HUMAN; OXIDATION; RAT;

ANIMALIA;

EID: 0029837171     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.3109/10715769609149056     Document Type: Article

References (16)

1. Srivastava, S. K., Ansari, N. H., Hair, G. A., Jaspan, J., Rao, M. B. and Das, B. (1986) Hyperglycaemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties. Biochemica et Biophysica Acta, 870, 302-311.
2. Barnett, P. A., Gonzalez, R. G. and Chylack, L. T. (1986) The effect of oxidation on sorbitol pathway kinetics. Diabetes, 35, 426-432.
3. De-Mattia, G., Laurenti, O., Bravi, C., Ghiselli, A., Iuliano, L. and Balsano, F. (1994) Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients. Metabolism, 43, 965-968.
4. Jiang, Z. Y., Zhou, Q. L., Eaton, J. W., Koppenol, W. H., Hunt, J. V. and Wolff, S. P. (1991) Spirohydantion inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro. Biochemical Pharmcology, 42, 1273-1278.
5. Wolff, S.P., Wang, G.M. and Spector, A. (1987) Pro-oxidant activation of ocular reductants. I. Copper and riboflavin stimulate ascorbate oxidation causing lens epithelial cytotoxicity in vitro. Experimental Eye Research, 45, 777-789.
6. Song, H. P., Das, B. and Srivastava, S. K. (1987) Micro-determination of aldose and aldehyde reductases from human tissues. Current Eye Research, 6, 1001-1006.
7. Jiang, Z. Y., Woollard, A. C. S. and Wolff, S. P. (1991) Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids, 26, 853-856.
8. Margoliash, E., Novogrodsky, A. and Schejter, A. (1960) Irreversible reaction of 3-amino-1.2.4.-triazole and related inhibitors with the protein of catalase. Biochemical Journal, 74, 339-348.
9. Ou, P. and Wolff, S. P. (1993) Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxides in vitro. Biochemical Pharmacology, 46, 1139-1144.
10. 2) production by ascorbic acid and glucose in the presence of aminotriazole: role of transition metals and relevance to diabetes. Biochemical Journal, 303, 935-940.
11. Hunt, J. V., Dean, R. T. and Wolff, S. P. (1988) Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochemical Journal, 256, 243-250.
12. Kador, P. F., Kinoshita, J. H. and Sharpless, N. E. (1986) The aldose reductase inhibitor site. Metabolism, 35, (No 4, suppl 1): 109-113.
13. Cheng, H. M. and Gonzalez, R. G. (1986) The effect of high glucose and oxidative stress on lens metabolism, aldose reductase and senile cataractogenesis. Metabolism, 35, (supple 1, April): 10-14.
14. Yeh, L. A. and Ashton, M. A. (1990) The increase of lipid peroxidation in rat diabetic lens can be reversed by oral sorbinil. Metabolism, 39, 619-620.
15. Wolff, S. P. and Crabbe, M. J. C. (1985) Low apparent aldose reductase activity produced by monosaccharide autoxidation. Biochemical Journal, 226, 625-630.
16. Jeremy, Y. J., Kontoghiorges, G. J., Hoffbrand, A. V. and Pandona, P. (1988) The iron chelators desferrioxamine and the 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro. Biochemical Journal, 254, 239-244.